Get a free weekly newsletter with recipe!

Market for Type 2 Diabetes Drug Expected to Double in 10 Years

Emma | October 25th, 2012

Warning: Illegal string offset 'default_custom_tag' in /home1/ab11795/public_html/livehealthy-md.com/wp-content/plugins/soundst-hidden-text/hidden_text.php on line 137

Warning: Illegal string offset 'default_activated_custom_tag' in /home1/ab11795/public_html/livehealthy-md.com/wp-content/plugins/soundst-hidden-text/hidden_text.php on line 138

Warning: Illegal string offset 'hidden_text' in /home1/ab11795/public_html/livehealthy-md.com/wp-content/plugins/soundst-hidden-text/hidden_text.php on line 139

Over the next decade, the type 2 diabetes medication market is expected to nearly double, soaring from $26 billion in 2011 to $50 billion in 2021. The increase can be attributed to a burgeoning pharmaceutical industry, but also to an increase in diabetes patients around the world.

Notably, while diabetes drugs have their place, many patients are able to control their condition with a diabetic diet alone. In fact, physician-assisted programs, such as those offered through The Center for Medical Weight Loss, have had great success in reversing diabetes with diet – and helping diabetics lose weight and keep it off. Imagine never having to pop another diabetes pill again.

Diabetes drug industry expected to reach $50 billion by 2021

Decision Resources, a top research and advisory firm for the pharmaceutical industry and healthcare issues, estimates that the market for type 2 diabetes drugs will almost double in the next decade. Specifically, Decision found that the $26 billion industry (2011) is expected to climb to nearly $50 billion by 2021, for markets in the United States, France, Germany, Italy, Japan, Spain, and the United Kingdom. The research firm explains some of the major factors influencing the rapid growth, including a large number of new products and an ever-increasing population of diabetes patients who use prescription drugs as part of their treatment.

Certain diabetes drugs decline due to potentially deadly side effects

Over the next 10 years, the dipeptidyl peptidase IV (DPP-IV) inhibitor drug class is expected to grow rapidly, reaching a 28% market share by 2012. Merck’s Januvia/Xelevia, part of the DPP-IV class, will likely lead the category, as other similar drugs lack significant clinical advantages over the medication. On the flip side, the PPAR-gamma agonist class will continue to decrease in popularity due to the risk of serious side effects. This drug class includes medications like Avandia and Actos, both of which have been associated with very serious risks, such as bladder cancer and heart attack.

Diabetic diet guidelines can eliminate need for medication

All prescription drugs, including diabetes medications, come with side effects, and it is always important for patients to evaluate whether the benefits outweigh the risks. However, many patients with diabetes may actually be able to treat their type 2 diabetes with diet alone. A physician-assisted diabetic diet is safe and customized to each patient’s specific needs and requirements. In reversing diabetes with diet, patients also learn how to make healthy food choices and incorporate daily exercise. The diabetes diet for weight loss is not just an eating program – it’s a lifestyle.

When embarking on a diabetic diet plan, it is absolutely essential to consult with a medical professional to determine required medication levels throughout your diet and weight loss. The physicians at The Center for Medical Weight Loss have helped countless patients lose weight quickly and successfully.

Become your own success story. To find the Center nearest you, simply enter your information into the box at top right. Special offers are available at some Centers to new clients.